These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 32149393

  • 1. Submandibular duct ligation after botulinum neurotoxin A treatment of drooling in children with cerebral palsy.
    Bekkers S, Pruijn IMJ, Van Hulst K, Delsing CP, Erasmus CE, Scheffer ART, Van Den Hoogen FJA.
    Dev Med Child Neurol; 2020 Jul; 62(7):861-867. PubMed ID: 32149393
    [Abstract] [Full Text] [Related]

  • 2. Surgery versus botulinum neurotoxin A to reduce drooling and improve daily life for children with neurodevelopmental disabilities: a randomized controlled trial.
    Bekkers S, Pruijn IMJ, van der Burg JJW, van Hulst K, Kok SE, Delsing CP, Scheffer ART, van den Hoogen FJA.
    Dev Med Child Neurol; 2021 Nov; 63(11):1351-1359. PubMed ID: 33997959
    [Abstract] [Full Text] [Related]

  • 3. Submandibular gland botulinum neurotoxin A injection for predicting the outcome of submandibular duct relocation in drooling: a retrospective cohort study.
    Kok SE, van Valenberg HFJP, van Hulst K, Jongerius P, Erasmus CE, van den Hoogen FJA.
    Dev Med Child Neurol; 2019 Nov; 61(11):1323-1328. PubMed ID: 30854648
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Randomized controlled trial comparing botulinum vs surgery for drooling in neurodisabilities.
    Bekkers S, Delsing CP, Kok SE, van Hulst K, Erasmus CE, Scheffer ART, van den Hoogen FJA.
    Neurology; 2019 Mar 12; 92(11):e1195-e1204. PubMed ID: 30728311
    [Abstract] [Full Text] [Related]

  • 7. Predicting non-response to intraglandular botulinum neurotoxin A injections for drooling in children with neurodevelopmental disabilities.
    Orriëns LB, van Hulst K, Willemsen MAAP, van den Hoogen FJA, Erasmus CE.
    Dev Med Child Neurol; 2024 Jul 12; 66(7):919-930. PubMed ID: 38140924
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness and safety of botulinum toxin in comparison with surgery for drooling in paediatric patients with neurological disorders: a systematic review.
    Silva JPS, Faria LV, Almeida RC, Medeiros YL, Guimarães LDA.
    Br J Oral Maxillofac Surg; 2022 Jun 12; 60(5):e691-e701. PubMed ID: 35227530
    [Abstract] [Full Text] [Related]

  • 9. Effect of botulinum toxin in the treatment of drooling: a controlled clinical trial.
    Jongerius PH, van den Hoogen FJ, van Limbeek J, Gabreëls FJ, van Hulst K, Rotteveel JJ.
    Pediatrics; 2004 Sep 12; 114(3):620-7. PubMed ID: 15342830
    [Abstract] [Full Text] [Related]

  • 10. Unsuccessful submandibular duct surgery for anterior drooling: Surgical failure or parotid gland salivation?
    Delsing CPA, Bekkers S, van Hulst K, Erasmus CE, van den Hoogen FJA.
    Int J Pediatr Otorhinolaryngol; 2019 Aug 12; 123():132-137. PubMed ID: 31102967
    [Abstract] [Full Text] [Related]

  • 11. An evaluation of predictors for success of two-duct ligation for drooling in neurodisabilities.
    Bekkers S, van Hulst K, Erasmus CE, Delsing CP, Scheffer ART, van den Hoogen FJA.
    J Neurol; 2020 May 12; 267(5):1508-1515. PubMed ID: 32025794
    [Abstract] [Full Text] [Related]

  • 12. Negative effects of submandibular botulinum neurotoxin A injections on oral motor function in children with drooling due to central nervous system disorders.
    van Hulst K, Kouwenberg CV, Jongerius PH, Feuth T, van den Hoogen FJ, Geurts AC, Erasmus CE.
    Dev Med Child Neurol; 2017 May 12; 59(5):531-537. PubMed ID: 27901263
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Changes in severity and impact of drooling after submandibular gland botulinum neurotoxin A injections in children with neurodevelopmental disabilities.
    Van Hulst K, Van Der Burg JJ, Jongerius PH, Geurts AC, Erasmus CE.
    Dev Med Child Neurol; 2020 Mar 12; 62(3):354-362. PubMed ID: 31729034
    [Abstract] [Full Text] [Related]

  • 15. Factors in the Efficacy, Safety, and Impact on Quality of Life for Treatment of Drooling with Botulinum Toxin Type A in Patients with Cerebral Palsy.
    Gonzalez-L MD, Martinez C, Bori Y Fortuny I, Suso-Vergara S.
    Am J Phys Med Rehabil; 2017 Feb 12; 96(2):68-76. PubMed ID: 28099276
    [Abstract] [Full Text] [Related]

  • 16. Botulinum toxin effect on salivary flow rate in children with cerebral palsy.
    Jongerius PH, Rotteveel JJ, van Limbeek J, Gabreëls FJ, van Hulst K, van den Hoogen FJ.
    Neurology; 2004 Oct 26; 63(8):1371-5. PubMed ID: 15505151
    [Abstract] [Full Text] [Related]

  • 17. Effects of salivary gland botulinum Toxin-A on drooling and respiratory morbidity in children with neurological dysfunction.
    Gubbay A, Marie Blackmore A.
    Int J Pediatr Otorhinolaryngol; 2019 Sep 26; 124():124-128. PubMed ID: 31185343
    [Abstract] [Full Text] [Related]

  • 18. Pediatric Sialorrhea: Submandibular Duct Rerouting and Intraparotid Botulinum Toxin A Injection With Literature Review.
    Calim OF, Hassouna HNH, Yildirim YS, Dogan R, Ozturan O.
    Ann Otol Rhinol Laryngol; 2019 Feb 26; 128(2):104-112. PubMed ID: 30371109
    [Abstract] [Full Text] [Related]

  • 19. Comparing botulinum toxin and 4-duct ligation for Sialorrhea in children - A systematic review.
    Ha TN, Shih MC, Lambert EM.
    Am J Otolaryngol; 2024 Feb 26; 45(2):104119. PubMed ID: 38043299
    [Abstract] [Full Text] [Related]

  • 20. Comparing the evidence for botulinum neurotoxin injections in paediatric anterior drooling: a scoping review.
    Orriëns LB, van Hulst K, van der Burg JJW, van den Hoogen FJA, Willemsen MAAP, Erasmus CE.
    Eur J Pediatr; 2024 Jan 26; 183(1):83-93. PubMed ID: 37924348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.